En Es
Categories

Industry News

Abbott Closes Acquisition of Alere

By Labmedica International staff writers
11 Oct 2017

Image: Abbott has closed the acquisition of Alere (Photo courtesy of iStock).Abbott (?Lake Bluff, IL; USA) has closed the acquisition of Alere, Inc. (Waltham, MA; USA), following the receipt of all regulatory clearances required for the closing.

Abbott is a global healthcare company with a portfolio of offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, while Alere focuses on rapid diagnostics for cardiometabolic disease, infectious disease and toxicology. The transaction makes Abbott the global leader in point of care testing and further strengthens the company's diagnostics presence.

Point of care testing is a USD 7 billion segment of the USD 50 billion in vitro diagnostics market and is growing rapidly as a number of health care systems are increasing their reliance on these technologies to inform patient care decisions with easy-to-use tests that provide speed and accuracy, particularly in the outpatient setting. With the addition of Alere, Abbott has approximately USD 7 billion in diagnostics sales worldwide, including about USD 2.5 billion in point of care testing.

“Creating the world's leading point of care business will help Abbott meet the growing demand for fast, accurate and actionable information,” said Brian Blaser, executive vice president, Diagnostics Products, Abbott. “Combined with Abbott's existing point of care business and its leading hand-held platform, i-STAT, we now have the broadest point of care testing portfolio to help improve care for patients in more parts of the world.”



E-mail Print
FaceBook Twitter Google+ Linked in

More articles about ABBOTT

13 Dec 2016
Abbott Seeks to Terminate Alere Acquisition
Abbott Laboratories has filed a complaint in the Delaware Court of Chancery seeking termination of its proposed acquisition of Alere, citing material adverse events after both the companies had entered into a merger agreement on January 30, 2016.
Read More

Additional news

17 Oct 2017
Ortho Clinical Diagnostics and EKF Diagnostics Collaborate for Assay
Ortho Clinical Diagnostics and EKF Diagnostics have entered into an agreement that allows Ortho customers to access the Beta-Hydroxybutyrate (BHB) assay, an important marker used in conjunction with clinical findings and other lab tests for the diagnosis and management of ketoacidosis and its main causative factor, diabetic ketoacidosis (DKA). The fully automated assay is now available for use on Ortho's VITROS 4600 chemistry system and the VITROS 5600 integrated system.
Read More
16 Oct 2017
Release of X-Ray Database to Boost AI Research
The U.S. National Institutes of Health (NIH) recently made available a massive database of chest X-rays, marking a huge step toward integrating artificial intelligence (AI) mechanisms into clinical practice.
Read More
16 Oct 2017
BioVendor Acquires All Shares of DIAsource ImmunoAssays SA
BioVendor - Laboratornímedicínaa.s., an international diagnostics holding, has acquired 100% of the shares of DIAsourceImmunoAssays SA from Anteo Diagnostics, which had acquired DIAsource in January 2016.
Read More
16 Oct 2017
Handheld Scanners Market to Reach USD 725 Million by 2027
The global handheld ultrasound scanners market is projected to grow at a robust CAGR of 8.8% from around USD 311 million in 2017 to about USD 725 million by 2027 end, driven mainly by the increasing use of handheld ultrasound scanners among non-radiologists and modernization in healthcare, coupled with high investment in research and development (R&D).
Read More
16 Oct 2017
Siemens Healthineers Enters Agreement with HORIBA Medical
Siemens Healthineers and HORIBA Medical have entered into a long-term agreement to bring new and innovative hematology solutions to the market globally.
Read More
11 Oct 2017
Companies with Lab-Developed Tests Raise USD 2 Billion
Companies with laboratory-developed tests (LTDs), tests performed by laboratories owned by IVD companies and others, are attracting increasing investor interest and raised over USD 2 billion between January and August 2017. These are the latest findings of Kalorama Information, an independent medical market research firm.
Read More
10 Oct 2017
IBM Watson Uses AI to Determine Patients Who Need Contrast
Researchers at the University of California, San Francisco (UCSF) have discovered that IBM Watson can help optimize the process of determining which patients need contrast for musculoskeletal MRI scans.
Read More
10 Oct 2017
Toshiba to Change Name to Canon in January
Toshiba Medical Systems Corporation will change its company name to Canon Medical Systems Corporation on January 4, 2018. The decision by Toshiba Medical to change the company’s name comes after it officially became a subsidiary of Canon Inc. in December 2016.
Read More
09 Oct 2017
Top Trends Impacting Global POC Testing Market
The global point-of-care (POC) HbA1C testing market is projected to grow at a CAGR of almost 9% from 2017-2021, driven mainly by the unhealthy lifestyles of people resulting in increased prevalence of diabetes and obesity, easy patient accessibility to POC tests and faster availability of results as compared to conventional laboratory testing procedures.
Read More
Copyright © 2000-2017 TradeMed.com. All rights reserved. | Terms And Conditions